Integrating muscle mass assessment with circulating myokine profiling (myostatin, irisin, IL-15) has been proposed as a strategy to identify metabolically vulnerable obesity phenotypes, supported by emerging multi-center clinical evidence [79]. This evidence concerns the gene FNDC5 and obesity disorder.